FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:59 July 2, 1998 Number 1

	Since this article has no abstract, we have provided an extract of the first 100% of the full text and any section headings.

	Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Goldstein, I.

Oral Sildenafil in the Treatment of Erectile Dysfunction . On page 1397, the first sentence of the abstract should have read, "Sildenafil is a potent inhibitor of cyclic guanosine monophosphate hydrolysis in the corpus cavernosum," not "a potent inhibitor of cyclic guanosine monophosphate in the corpus cavernosum," as printed. Also, on page 1399, the second sentence under the heading "Results" should have read, "The men in the dose-escalation study had had erectile dysfunction for longer periods," not "The men in the dose–response study," as printed.

This article has been cited by other articles:

• Lau, D. H W, Mumtaz, F. H, Thompson, C. S, Mikhailidis, D. P (2004). Erectile dysfunction: a need for greater awareness. The Journal of the Royal Society for the Promotion of Health 124: 214-216 [Abstract]  
• Fazio, L., Brock, G. (2004). Erectile dysfunction: management update. CMAJ 170: 1429-1437 [Abstract] [Full Text]